Sau San Tong Holdings Limited (8200) AI Stock Analysis

• Market Cap: HK$48.09M
• Dividend Yield: N/A
• Average Volume (3M): 4.76K
• Price to Earnings (P/E): 44.9
• Beta (1Y): 0.52
• Revenue Growth: 1.01%
• EPS Growth: N/A
• Country: HK
• Employees: 198
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): 0.21
• Shares Outstanding: 78,842,030
• 10 Day Avg. Volume: 4,830
• 30 Day Avg. Volume: 4,763
• PEG Ratio: >-0.01
• Price to Book (P/B): 0.05
• Price to Sales (P/S): 0.04
• P/FCF Ratio: -1.24
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 45 Neutral
• Price Target: HK$0.59 ▼(-15.22% Downside)

The score is primarily weighed down by poor financial performance (negative margins and negative operating/free cash flow). Technicals are relatively neutral with only modest momentum signals, while valuation is a headwind due to a high P/E and no dividend yield support.

Positive Factors

Diversified business model

A diversified model spanning hospitals/clinics, real estate leasing/sales and financial services provides multiple durable revenue streams. This mix can smooth cyclical healthcare demand, enable cross‑selling, and allow capital redeployment between segments to support long‑term stability.

Conservative leverage

Very low leverage materially reduces refinancing and solvency risk, giving management optionality to invest in facility upgrades or acquisitions without pressuring cash flow. Over 2–6 months this balance sheet conservatism supports resilience amid operational turnarounds.

Stable equity base

A stable equity ratio implies a solid capital base to absorb losses and fund operations, lowering bankruptcy risk. For a healthcare operator, that stability supports long‑term investments in clinical capability and property assets that underpin recurring revenue.

Negative Factors

Weak cash generation

Sustained negative operating and free cash flow undermines the firm's ability to fund operations, capex, or service growth internally. Over months this drives dependence on external financing or asset disposals, constraining strategic flexibility and long‑term viability.

Consistent unprofitability

Persistent negative margins and operating losses indicate structural issues in cost control, pricing, or mix. Without margin recovery, profitability is unlikely to be sustainable, eroding retained earnings and making it harder to reinvest in clinical services or property maintenance.

Declining revenue trend

A recent decline in revenue signals demand or market share challenges that can persist without strategic changes. For a healthcare and property investor, prolonged top‑line contraction pressures margins and cash flow, limiting ability to scale services or realize property income long term.

Sau San Tong Holdings Limited Business Overview & Revenue Model

Company Description

Sau San Tong Holdings Limited, an investment holding company, engages in the distribution and sale of cosmetic and skin care products. It also provides beauty and slimming services, such as whole and partial body slimming, weight management, body treatment, and facial treatment services through its slimming centers operated under the Sau San Tong and IPRO brands. In addition, the company is involved in the sale of other health and beauty products; property holding; money lending; and investment in securities. Further, it offers management consultancy, advertising agency, and franchise services; and a proprietary internet platform to promote and sell slimming beauty, and health related services and products. The company operates five beauty and slimming centers in Hong Kong. Sau San Tong Holdings Limited was founded in 2000 and is headquartered in Central, Hong Kong.

How the Company Makes Money

Sau San Tong Holdings Limited generates revenue through multiple streams, primarily by operating its healthcare facilities, which include hospitals and clinics, where it earns income from patient services, consultations, and medical procedures. Additionally, the company benefits from investments in real estate, deriving income from property leasing and sales. The firm may also have strategic partnerships with government agencies and other healthcare providers, enhancing its service capabilities and expanding its market reach, which contributes significantly to its earnings. Furthermore, any financial services offered by the company could provide an additional revenue stream, offering products like insurance or financing solutions related to healthcare.

Sau San Tong Holdings Limited Financial Statement Overview

Summary

Weak operating performance: declining revenue, consistently negative profit margins, and negative EBIT/EBITDA margins. Balance sheet leverage is low, but negative ROE and negative operating/free cash flow point to ongoing profitability and cash-generation risk.

Income Statement

Sau San Tong Holdings Limited has experienced declining revenue over recent years, with a negative revenue growth rate of -2.37% in the latest year. The company has consistently reported negative net profit margins, indicating ongoing profitability challenges. Gross profit margins have also decreased, reflecting potential issues in cost management or pricing strategy. The EBIT and EBITDA margins are negative, highlighting operational inefficiencies.

Balance Sheet

The company's balance sheet shows a low debt-to-equity ratio of 0.0186, suggesting conservative leverage and low financial risk. However, the return on equity is negative, indicating that the company is not generating sufficient returns on shareholders' equity. The equity ratio is relatively stable, reflecting a solid equity base compared to total assets.

Cash Flow

Cash flow analysis reveals significant challenges, with negative operating and free cash flows in the latest year. The free cash flow growth rate is highly negative, indicating deteriorating cash generation capabilities. The operating cash flow to net income ratio is negative, suggesting that the company is struggling to convert its earnings into cash.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.06B	840.02M	1.09B	1.23B	1.56B	1.79B
Gross Profit	66.40M	49.60M	104.57M	99.12M	137.17M	144.49M
EBITDA	-40.90M	-31.15M	6.59M	9.90M	41.94M	21.82M
Net Income	-59.81M	-51.98M	-14.30M	-13.93M	8.95M	-26.42M
Balance Sheet
Total Assets	770.90M	770.90M	843.36M	901.34M	961.20M	982.77M
Cash, Cash Equivalents and Short-Term Investments	419.43M	419.43M	492.91M	523.28M	529.27M	537.96M
Total Debt	13.26M	13.26M	9.53M	5.44M	6.59M	11.53M
Total Liabilities	81.28M	81.28M	87.35M	125.64M	141.19M	174.49M
Stockholders Equity	714.66M	714.66M	770.03M	789.65M	807.44M	800.28M
Cash Flow
Free Cash Flow	-26.17M	-26.17M	-11.23M	23.10M	-18.13M	44.62M
Operating Cash Flow	-25.05M	-25.05M	-5.55M	41.13M	-5.70M	47.28M
Investing Cash Flow	378.00K	378.00K	-5.64M	-17.84M	-12.05M	22.05M
Financing Cash Flow	-21.27M	-21.27M	-9.36M	-29.84M	-20.74M	-13.66M

Sau San Tong Holdings Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.69
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8200, the sentiment is Positive. The current price of 0.69 is above the 20-day moving average (MA) of 0.62, above the 50-day MA of 0.59, and above the 200-day MA of 0.54, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 49.91 is Neutral, neither overbought nor oversold. The STOCH value of 57.18 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8200.

Sau San Tong Holdings Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
3332	62 Neutral	HK$648.05M	21.39	3.92%	―	-0.92%	-71.88%
2023	58 Neutral	HK$368.85M	6.40	10.92%	―	11.10%	-4.38%
1259	48 Neutral	HK$70.51M	-1.34	-8.59%	―	-1.48%	-16.04%
8200	45 Neutral	HK$48.09M	44.85	0.15%	―	1.01%	―
8281	45 Neutral	HK$104.00M	15.76	2.37%	―	-1.65%	230.00%
0157	41 Neutral	HK$940.99M	-15.11	-12.38%	―	39.29%	-71.82%